Great News for High-Risk Breast Cancer Patients
Great news for high-risk breast cancer patients who have early stage or advanced metastasized...
Home » FDA Approval
by Kendra Evans | Mar 21, 2022 | Cancer, Lynparza (olaparib)
Great news for high-risk breast cancer patients who have early stage or advanced metastasized...
by Kendra Evans | Jun 11, 2021 | Aduhelm (aducanumab), Alzheimer's, Diseases & Conditions, Drugs, Neurology | 0 |
The FDA grants accelerated approval for Aduhelm (aducanumab), the first-of-its-kind treatment...
Read Moreby Kendra Evans | Sep 1, 2021 | Aduhelm (aducanumab), Alzheimer's, Diseases & Conditions, Drugs, Neurology | 0 |
Alzheimer’s Disease was supposed to get a new opponent after Biogen Inc. received unexpected...
Read Moreby Kendra Evans | Jan 18, 2022 | Akylosing Spondylitis, Arthritis, Atopic Dermatitis, Autoimmune, Crohn's Disease, Digestive Disorders, Diseases & Conditions, Drugs, Eczema, Psoriasis, Rheumatoid Arthritis, Rinvoq (upadacitinib), Skin Disorders, Ulcerative colitis | 0 |
Good news for people age 12 and up that suffer from the endless cycle of itching and scratching...
Read Moreby Kendra Evans | Mar 21, 2022 | Cancer, Lynparza (olaparib) | 0 |
Great news for high-risk breast cancer patients who have early stage or advanced metastasized...
Read More